The Victorian Comprehensive Cancer Centre Alliance, or VCCC Alliance for short, is a Victorian partnership of 10 research, academic and clinical institutions looking at improving cancer outcomes for patients:
- Peter MacCallum Cancer Centre
- The Royal Melbourne Hospital
- University of Melbourne
- The Royal Women’s Hospital
- WEHI
- The Royal Children’s Hospital
- Western Health
- St Vincent’s Hospital Melbourne and St Vincent’s Institute
- Austin Health and Olivia Newton-John Cancer Research Institute
- Murdoch Children’s Research Institute
The VCCC Alliance SKILLED clinical trial internships program is a pathway for scientists to build role-specific clinical trial knowledge, experience and in a clinical trials unit through theoretical and on-the-job training. The internship program is a 40 week intensive program to get science student interns job ready for clinical trial assistant and study coordinator internship roles.
The program is funded in part by MTPConnect’s $32 million REDI initiative, supported by the Medical Research Future Fund. Now into it’s 4th year, VCCC Alliance’s SKILLED Clinical Trials Internship program commenced in 2019 and by year end 2022 would have placed 77 interns into clinical trial units.
Australian Health Journal spoke with Chris Packer, Manager, SKILLED Clinical Trials Internship program at the VCCC Alliance about the need to build capacity of clinical trial units, especially with reductions on overseas travellers in the sector and other factors leading to gaps in the workforce.
In 2022, 22 intern have been placed in large tertiary facilities as well as in regional Victoria.
Australian Health Journal spoke with 2 recent interns about their experiences during and following the internship program:
- Dulash Fernando, Clinical Trials Assistant
- Rebecca Komesaroff, VCCC Skilled Intern (CTA)
Australian Health Journal also spoke to some of the host sites about the program and the important need to fill the clinical trial skills gap.
- Dr Sarah Rickard, Director Research Governance and Ethics, The Royal Melbourne Hospital
- Kate Scarff, Clinical Research Development Office Lead, Melbourne Children’s Trials Centre, Murdoch Children’s Research Institute
- Narelle McPhee, Cancer Research Manager, Bendigo Health
Narelle talks about the importance and uniqueness of the internship program for the staff in the Bendigo region. She sees the program as a strong partnership with VCCC Alliance, the intern and the clinical trials unit in Bendigo Health, that helps with future recruitment as well bringing new perspectives. There are opportunities in regional and rural locations undertaking clinical trials, and Narelle happily states, the interns they have previously hosted have gained employment in the region.
Internship evaluations by interns and the host sites in 2021 Net Promotor Scores (NPS) have shown high levels of satisfaction levels both from interns and host sites in the program. As further testament to its success, 95% of interns have gone back into the clinical trial sector since the commencement of the program.
Produced with assistance from:
ARCS Australia
-
Developing the next generation of medicines to target and enhance the microbiome
Australian Health Journal spoke to Associate Professor Sam Forster, Research Group Head
Microbiota and Systems Biology, Hudson Institute of Medical Research, Team Leader, Australian Microbiome Culture Collection & Chief Scientific Officer, BiomeBank and Dr Sam Costello, Co-Founder and CEO of BiomeBank about the microbiome, partnering and some of the breakthroughs in recent years. -
Physiotherapist, exercise physiologist support for management of osteoporosis
Osteoporosis is commonly managed medically and typically with treatment. Exercise is also essential in the management of osteoporosis but tends to be under-utilised due to lack of knowledge and unfounded concerns about the risk of injury. In fact, optimal care of people with low bone mass, osteoporosis and/or increased risk of falling can and should include targeted exercise to help prevent osteoporotic fracture.
In early 2024, Healthy Bones Australia released a summary of the principles of osteogenic loading and fall prevention, the translation of those principles into clinical practice, evidence-based recommendations for exercise prescription, and special considerations, along with links to several relevant resources for people with or at risk of osteoporosis, falls and fractures.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
